MedTrace Logo

Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia

NCT06229860 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2026-03-10

No results posted yet for this study

Summary

This is an observational pilot study to examine the association between a patient's personality and adherence to tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.

Conditions

  • Chronic Myeloid Leukemia
  • Chronic Phase Chronic Myelogenous Leukemia

Interventions

OTHER

Interview

In-person interview with the study coordinator to complete study questionnaire.

Sponsors & Collaborators

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Mahtab Jafari, Pharm.D · Chao Family Comprehensive Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-25
Primary Completion
2025-03-19
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06229860 on ClinicalTrials.gov